METTL3 could also drive hepatocellular carcinoma progression by mediating m6A modification of ubiquitin-specific processing protease 7 (USP7) [11] or abnormal spindle-like microcephaly (ASPM) [12]. Here, METTL3 is linked to hepatocellular carcinoma.